SCHEMBL3055047

SCHEMBL3055047

O=[N+]([O-])Sc1ccccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 2/20 0.39
▸ CTSB P07858 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ APEX1 P27695 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ GMNN O75496 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ CA3 P07451 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1336721 0.84 LMNA (0.42) ALDH1A1MAPTSMN1; SMN2LMNAKDM4E
SCHEMBL3044512 0.77 PDE7A (0.37) ALDH1A1MAPTSMN1; SMN2LMNAKDM4E
SCHEMBL3838786 0.74 PDE7A (0.35) ALDH1A1MAPTSMN1; SMN2LMNAKDM4E
SCHEMBL5833149 0.74 PDE7A (0.56) ALDH1A1MAPTALOX15SMN1; SMN2LMNA
SCHEMBL28351783 0.74 LMNA (0.46) ALDH1A1MAPTSMN1; SMN2LMNAHPGD
SCHEMBL8746025 0.74 MAPT (0.37) GPR35CTSBALDH1A1MAPTALOX15
SCHEMBL9635033 0.74 APOBEC3G (0.55) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL31163274 0.74 POLB (0.59) ALDH1A1MAPTALOX15SMN1; SMN2LMNA
SCHEMBL2461047 0.74 POLB (0.59) ALDH1A1MAPTALOX15SMN1; SMN2LMNA
SCHEMBL11554587 0.72 SIRT1 (0.53) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 — — US claimed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 — — US claimed
EP-0905124-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 — — EP claimed
EP-0905123-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 — — EP claimed
EP-0918050-B1 Bis-o-amino(thio)phenols and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 — — EP claimed
US-6096921-A USED FOR THE PREPARATION OF HIGH-TEMPERATURE-STABLE POLYMERS, SUCH AS POLYBENZOXAZOLES AND POLYBENZTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2000-08-01 — — US claimed
EP-0918050-A1 Bis-o-amino(thio)phenols and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-05-26 — — EP claimed
EP-0905123-A1 o-amino(thio)phenol-carboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 — — EP claimed
EP-0905124-A1 o-amino(thio)phenol-carboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 — — EP claimed
JP-11158128-A — — None — — JP disclosed
US-8431699-B2 Method for manufacture of 2-oxoimidazolidines Vertichem Corporation (CA) 2013-04-30 — — US disclosed
WO-2010099518-A2 METHOD FOR MANUFACTURE OF 2-OXOIMIDAZOLIDINES THESIS CHEMISTRY, LLC (US) 2010-09-02 — — WO disclosed
US-20100222588-A1 Method for Manufacture of 2-Oxoimidazolidines THESIS CHEMISTRY, LLC (US) 2010-09-02 — — US disclosed
US-6627714-B2 Copolymerizing ethylene and dicyclopentadiene or tricyclopentadiene, and cyclic olefin in presence of metallocene catalyst to produce copolymer MARUZEN PETROCHEMICAL CO., LTD. (JP) 2003-09-30 — — US disclosed
US-3987050-A SUBSTITUTED PYRIDINYLALKOXY-, PYRIDINYLALKYLSULFONYL AND PYRIDINYLALKYLTHIO-PHENYL-LOWER-ALKANAMIDES THE DOW CHEMICAL COMPANY (US) 1976-10-19 — — US disclosed
US-3962265-A H'-(4-((6-CHLORO-2-PYRIDINYL)OXY)PHENYL)-N-METHYL-N-(1-METHYL-2-PROPYNYL)UREA THE DOW CHEMICAL COMPANY (US) 1976-06-08 — — US disclosed
US-3947437-A Substituted pyridazinyloxy(thio)phenyl ureas and derivatives thereof THE DOW CHEMICAL COMPANY (US) 1976-03-30 — — US disclosed
US-3940392-A Certain pyrazinyloxyphenyl urea compound THE DOW CHEMICAL COMPANY (US) 1976-02-24 — — US disclosed
US-3931200-A Substituted pyridinylalkoxy-, pyridinylalkylsulfonyl- and pyridinylalkylthio- phenylureas THE DOW CHEMICAL COMPANY (US) 1976-01-06 — — US disclosed
US-3931201-A HERBICIDE THE DOW CHEMICAL COMPANY (US) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT GPR35 2961/4885CTSB 3810/4885ALDH1A1 424/4885
US-20100222588-A1 Method for Manufacture of 2-Oxoimidazolidines ODC1, CBR3, CBR1 GPR35 3497/4885CTSB 2456/4885ALDH1A1 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback